← Back to Search

Coenzyme Q10 Supplement

Impact of Orally Administered BPM31510 on Mitochondrial Energetics in Older Adults With Sarcopenia (COQ10 Trial)

Phase < 1
Waitlist Available
Led By Paul Coen, PhD
Research Sponsored by Translational Research Institute for Metabolism and Diabetes, Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up following 28 days of treatment

Summary

This trial is testing if taking CoQ10 pills can help older adults with muscle loss. The study lasts for about a month. Researchers want to see if CoQ10 improves muscle strength, aerobic capacity, and overall physical function by helping cells make more energy. Coenzyme Q10 (CoQ10) has been studied for its potential benefits in improving muscle metabolism, exercise performance, and reducing fatigue.

Eligible Conditions
  • Sarcopenia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~following 28 days of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and following 28 days of treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Measurement of platelet CoQ10 level
Measurement of skeletal muscle

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Older adults with sarcopenia (drug)Active Control1 Intervention
Group II: Older adults with sarcopenia (placebo)Placebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Translational Research Institute for Metabolism and Diabetes, FloridaLead Sponsor
40 Previous Clinical Trials
3,664 Total Patients Enrolled
2 Trials studying Sarcopenia
275 Patients Enrolled for Sarcopenia
AdventHealth Translational Research InstituteLead Sponsor
50 Previous Clinical Trials
5,964 Total Patients Enrolled
2 Trials studying Sarcopenia
275 Patients Enrolled for Sarcopenia
Paul Coen, PhDPrincipal InvestigatorAdventHealth Translational Research Institute
5 Previous Clinical Trials
191 Total Patients Enrolled
1 Trials studying Sarcopenia
75 Patients Enrolled for Sarcopenia
~0 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top